Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nitrocefin is a chromogenic cephalosporin substrate primarily used in laboratory settings to detect the presence of beta-lactamase enzymes produced by various bacteria. It contains a beta-lactam ring that is hydrolyzed by beta-lactamases, resulting in a visible color change from yellow (intact) to red (hydrolyzed), which allows for rapid and inexpensive detection of beta-lactamase activity. Nitrocefin does not have antimicrobial properties and is not used therapeutically; its main application is as a diagnostic reagent for identifying bacterial resistance mechanisms related to beta-lactam antibiotics[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nitrocefin.